Keros Therapeutics shares owned by OrbiMed Advisors
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by OrbiMed Advisors
from 13F filings
Historical chart of OrbiMed Advisors investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by OrbiMed Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $59M | 1.0M | 58.07 |
| 2024-06-30 | $58M | 1.3M | 45.70 |
| 2024-03-31 | $84M | 1.3M | 66.20 |
| 2023-12-31 | $50M | 1.3M | 39.76 |
| 2023-09-30 | $48M | 1.5M | 31.88 |
| 2023-06-30 | $61M | 1.5M | 40.18 |
| 2023-03-31 | $72M | 1.7M | 42.70 |
| 2022-12-31 | $81M | 1.7M | 48.02 |
| 2022-09-30 | $63M | 1.7M | 37.62 |
| 2022-06-30 | $46M | 1.7M | 27.63 |
| 2022-03-31 | $91M | 1.7M | 54.38 |
| 2021-12-31 | $98M | 1.7M | 58.51 |
| 2021-09-30 | $66M | 1.7M | 39.56 |
| 2021-06-30 | $71M | 1.7M | 42.47 |
| 2021-03-31 | $103M | 1.7M | 61.55 |
| 2020-12-31 | $119M | 1.7M | 70.54 |
| 2020-09-30 | $65M | 1.7M | 38.57 |
| 2020-06-30 | $63M | 1.7M | 37.51 |